<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00953628</url>
  </required_header>
  <id_info>
    <org_study_id>recHCG001</org_study_id>
    <nct_id>NCT00953628</nct_id>
  </id_info>
  <brief_title>Endometrial Advancement After Rec or u-HCG Triggering</brief_title>
  <official_title>Endometrial Advancement After Rec or u-HCG Triggering</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono International SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate any potential advantages of replacing human
      chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for
      final oocyte maturation with regard to Ovarian hyperstimulation syndrome
      (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biopsies of endometrium were taken in different groups Pregnancy rates were compared among
      defferent groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date>December 2008</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endometrium histology on the day of OPU</measure>
    <time_frame>day of oocytre pick up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>14 days after oocyte pick up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>o Group A=uHCG ovul trig</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HCG for triggering</description>
  </arm_group>
  <arm_group>
    <arm_group_label>o Group B=recHCG ovul trig</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>recombinant HCG for triggering</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10000 IU urinary HCG</intervention_name>
    <description>bolus 10000 units for ovulation triggering</description>
    <arm_group_label>o Group A=uHCG ovul trig</arm_group_label>
    <other_name>Pregnyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>250 mcg recombinant HCG</intervention_name>
    <description>bolus 250 mcg for ovulation triggering in IVF patients</description>
    <arm_group_label>o Group B=recHCG ovul trig</arm_group_label>
    <other_name>Ovitrelle</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Less than 36 years old

          -  Male or tubal infertility

          -  FSH&lt;12 on day 3

        Exclusion Criteria:

          -  Endometriosis stage 3 &amp; 4
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Devroey, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Professor or OB-GYN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Reproductive Medicine, UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <state>Jette</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.brusselsivf.be/taalkeuze.aspx</url>
    <description>main web page of the centre for reproductive medicine in UZ Brussels</description>
  </link>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2009</study_first_submitted>
  <study_first_submitted_qc>August 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>December 1, 2015</last_update_submitted>
  <last_update_submitted_qc>December 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Papanikolaou Evangelos</investigator_full_name>
    <investigator_title>Lecturer Aristotle University Greece</investigator_title>
  </responsible_party>
  <keyword>endometrium</keyword>
  <keyword>histology</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

